Hi-Tech Pharma Announces ECR Pharma Re-Launched Zolpimist, DexPak, Divestiture of Hylase, Orbivan Brands

Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.

Hi-Tech Pharmacal Co., Inc. (NASDAQ: HITK) today announced that its ECRPharmaceuticals division re-launched Zolpimist® Oral Spray (zolpidem tartrate)and DexPak® Taperpaks (dexamethasone tablets) through its proprietary salesforce at a series of launch meetings commencing this week.Additionally, ECR has divested its interest in non-core products Hylase® andOrbivan®. Hylase was divested for a one-time payment in January, and Orbivan®was divested in March for $500,000 over two payments and an ongoing royaltystream.

Crypto Whales Are Loading Up — Are You?

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!